Last checked at 24 Jan 2017 12:56
24 January 2017
Microsaic Systems plc
("Microsaic", "Microsaic Systems" or the "Company")
Appointment of Interim Chairman
Microsaic Systems plc (AIM: MSYS), the developer of chip-based mass spectrometry instruments, announces that it has appointed Prof. Eric Yeatman as Interim Chairman of the Board while the Company continues its search for a successor to Mr Colin Nicholl who retires as Chairman on 31 January 2017. Prof. Yeatman is an experienced chair, having previously held the position for nine years, resigning on 1 July 2013. Since 1 July 2013, he has been a Non-Executive Director of the Company.
The process to recruit a new Chairman is progressing, and discussions have been held with a number of potential candidates. The Company will keep shareholders updated on the recruitment process.
Separately, Mr Christopher Buckley, Non-Executive Director, will join the Remuneration Committee and Finance and Audit Committee.
Enquiries: | |
Microsaic Systems plc Jim Ramage, CEO Bevan Metcalf, FD | +44 (0) 1483 751577 |
N+1 Singer (Nominated Adviser & Broker) Shaun Dobson Liz Yong
|
+44 (0)20 7496 3000 |
Citigate Dewe Rogerson (Financial PR) Mark Swallow, Marine Perrier | +44 (0)20 7282 2948/1068 |
About Microsaic Systems
Microsaic Systems plc is a high technology company developing chip-based, bench-top mass spectrometry ("MS") instruments that are designed to improve the efficiency of Pharma R&D. MS is an analytical technique of choice for biochemists across many industry sectors.
Microsaic aims to bring routine MS analysis to the pharmaceutical scientist, providing powerful methods of analysis to enable earlier decision making relating to product identification, purity and bioactivity.
The Company is working with established global companies in preparative and purification science with expertise in Pharma and life sciences to co-develop new, integrated and optimised, application-specific, solutions to improve productivity in the development of small molecule and novel biologic (peptides, antibodies) medicines.
The Microsaic 4000 MiD®, single quadrupole, is the world's smallest MS system, retaining the functionality of larger conventional MS systems, is easier to use by non-specialists, consumes less energy and has lower running costs. The Company is also developing new MS systems, based on its patented chip technologies, to address further areas of emerging need in Pharma R&D.
Microsaic Systems was established in 2001 by a team including founders from Imperial College London, and was admitted to AIM in 2011 (ticker: MSYS).
www.microsaic.com